Envair Electrodyne Limited is a Pune-based industrial machinery company currently navigating a fundamental strategic pivot. Historically recognized for its expertise in contamination control and specialized workspace solutions, the company is transitioning from a traditional manufacturing model toward a capital-deployment and trading strategy. Following the disposal of its primary fixed assets in **2023**, the company is leveraging its cash reserves to invest in high-growth international ventures and new manufacturing opportunities. --- ### **Strategic Pivot: From Legacy Manufacturing to Global Investment** The company is currently in a transitional phase, moving away from internal manufacturing at its Pune plant to focus on **trading and contract manufacturing**. This shift is designed to reduce fixed operational overheads and capture higher margins. * **Asset Monetization:** During the first half of **FY 2023-24**, the company disposed of its **Fixed Assets**, including **Land, Building, Plant, and Machinery**. * **International Strategic Investment:** In **August 2023**, the Board approved an investment of up to **₹19 crore** in **Alliance Asia-Pac Pte. Ltd. (Singapore)**. * As of **February 2024**, the company acquired a **20% stake** in this entity. * The investment included the acquisition of **1,43,750 shares** at **USD 1.05 per share**. * **Underlying Asset:** The Singapore entity owns **PT Alliance Consumer Products Indonesia**, a soap manufacturing plant serving **Unilever PLC** across **20+ countries**, with an estimated **2023** turnover of **USD 100 Million**. * **New Business Exploration:** Management is actively evaluating new manufacturing projects and export-oriented trading opportunities (specifically targeting the **Indonesian market**) to ensure "Going Concern" status and improve shareholder returns. --- ### **Core Product Portfolio & Technical Capabilities** Despite the operational restructuring, the company maintains its identity within the **Industrial Machinery** segment, focusing on high-precision equipment for contamination control and industrial maintenance. | Product Category | Description & Application | | :--- | :--- | | **Clean Air Equipment** | Specialized filtration and purification systems for sensitive environments. | | **Electrostatic Cleaners** | Advanced systems designed to remove fine particulates from industrial air. | | **Air Showers** | Decontamination chambers for personnel entering **Clean Rooms**. | | **Clean Room Solutions** | Controlled environments for pharmaceutical, automotive, and electronic manufacturing. | | **Technical Furniture** | Ergonomic, specialized workstations for laboratories and high-tech workspaces. | | **Hydraulic Oil Cleaners** | Equipment dedicated to industrial fluid maintenance and longevity. | **Research & Development Focus:** * Integration of **Smart Functions** and automation into existing machinery lines. * Focus on **Technology Absorption** to reduce **Product Support Costs** and enhance customer productivity. * Implementation of **Demand Side Management** to maintain energy efficiency despite rising utility tariffs. --- ### **Financial Performance & Efficiency Metrics** The company’s financial profile reflects the volatility of its transition, moving from a profit driven by asset sales in **FY 2022-23** to an operational loss in **FY 2023-24**. | Metric | FY 2023-24 (Audited) | FY 2022-23 (Audited) | | :--- | :--- | :--- | | **Total Revenue** | **₹39,71,581** | **₹97,21,621** | | **Net Profit / (Loss) After Tax** | **(₹81,45,533)** | **₹6,08,17,380** | | **Net Profit Ratio** | **(2.05)** | **6.26** | | **Return on Capital Employed** | **(0.14)** | **1.44** | | **Authorized Share Capital** | **₹5.50 Crore** | **₹5.50 Crore** | | **Paid-up Share Capital** | **₹4.64 Crore** | **₹4.64 Crore** | **Key Financial Observations:** * **Revenue Contraction:** Total revenue declined by approximately **59%** year-on-year due to the cessation of legacy manufacturing. * **Exceptional Items (FY 2022-23):** The prior year's profit was bolstered by a **₹11.02 crore** premium from the surrender of lease rights, offset by fraud-related losses. * **Inventory Realization:** In June 2023, opening inventories valued at **₹45.69 Lakhs** were sold for **₹8.47 Lakhs**, reflecting a significant write-down during the exit from old product lines. * **Dividend Policy:** No dividend was recommended for **FY 2023-24** due to incurred losses. --- ### **Governance, Management & Audit Framework** The leadership team brings extensive experience in supply chain management and large-scale FMCG projects, which aligns with the company's new focus on contract manufacturing. * **Managing Director:** **Anil Nagpal** (Re-appointed until **2027**). He possesses **30+ years** of experience in Pharma/FMCG supply chains and has a track record of scaling group turnovers to **₹40 crore**. * **Independent Director:** **Rashmi Sharma** (Term until **Nov 2028**), a legal expert in taxation. * **Audit Structure:** * **Statutory Auditors:** **M.L. Bhuwania and Co LLP** (appointed for **FY 2025-26**). * **Internal Auditors:** **M/s. S.M Bhat & Associates**. * **Secretarial Auditors:** **M/s. Sanger & Associates** (Term until **March 2030**). --- ### **Risk Profile & Internal Control Remediation** The company faces several critical risks stemming from historical internal control lapses and its current "Going Concern" status. **1. Financial Fraud Incident:** A major digital fraud was discovered in **May 2023**, involving the unauthorized withdrawal of **₹1.91 crore** by the former Chief Accountant between **FY 2020-21** and **FY 2023-24**. * **Impact:** Led to a **Qualified Audit Opinion** for FY 2022-23 and penalties from the **BSE** for delayed filings. * **Remediation:** Management now requires personal verification of **Bank Reconciliation Statements** by Directors and original documentation for all transactions. **2. Operational & Liquidity Risks:** * **Going Concern Uncertainty:** Auditors have highlighted the lack of active manufacturing and consistent operating losses as significant risks. * **Unconfirmed Balances:** Balances for **Trade Receivables, Payables, and Deposits** remain subject to third-party confirmation. * **Stalled Advances:** A **₹30,00,000** advance for land acquisition from **May 2020** remains outstanding despite the deal failing to materialize. **3. Contingent Liabilities:** As of **March 31, 2025**, contingent liabilities have been reduced to **₹12.92 lakhs** (entirely Income Tax), down from **₹49.02 lakhs** in 2023. The company successfully resolved a **₹17.24 lakh GST dispute** during the period. | Liability Type (Historical - March 2023) | Amount (₹ Lakhs) | | :--- | :--- | | **GST (FY 2017-18 & 2018-19)** | **22.17** | | **Income Tax (FY 2022-23)** | **26.85** | | **Total** | **49.02** | --- ### **Future Outlook** Envair Electrodyne’s future is tied to the success of its **₹19 crore** investment in the Singapore-based **Alliance Asia-Pac** and its ability to pivot into the **Contract Manufacturing** of soaps and FMCG goods. By leveraging the promoter group’s **20+ years** of experience in this sector and identifying growth in the **Environmental Sector** (driven by global filtration regulations), the company aims to reverse its loss-making trend and establish a leaner, trading-heavy business model.